Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis

Amyloid

Volumn 20, Issue 2, 2013, Pages 99-106

  Wixner, Jonas ^a   Obayashi, Konen ^b   Ando, Yukio ^b   Karling, Pontus ^a   Anan, Intissar ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Amyloidosis; Enteric nervous system; Functional; Gastrointestinal disorders; Hereditary; Interstitial cell of Cajal; Transthyretin

Indexed keywords

PREALBUMIN; STEM CELL FACTOR RECEPTOR;

ADULT; ARTICLE; CELL DENSITY; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL AMYLOIDOSIS; FEMALE; HEREDITARY TRANSTHYRETIN AMYLOIDOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERSTITIAL CELL OF CAJAL; JAPANESE; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH ANTRUM;

ADULT; AGED; AGED, 80 AND OVER; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; CASE-CONTROL STUDIES; CHLORIDE CHANNELS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; INTERSTITIAL CELLS OF CAJAL; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM PROTEINS; NERVOUS SYSTEM; PREALBUMIN; PROTO-ONCOGENE PROTEINS C-KIT; SEX FACTORS; STOMACH;

EID: 84878267678     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2013.787985     Document Type: Article

References (43)

1. Olsson M, Hellman U, Planté-Bordeneuve V, Jonasson J, La°ng K, Suhr OB. Mitochondrial haplogroup is associated with the pheno-type of familial amyloidosis with polyneuropathy in Swedish and French patients. Clin Genet 2009;75:163-8.
2. Saraiva MJ. Transthyretin amyloidosis: a tale of weak interactions. FEBS Lett 2001;498:201-3.
3. Matsunaga N, Anan I, Forsgren S, Nagai R, Rosenberg P, Horiuchi S, Ando Y, et al. Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation. Acta Neuropathol 2002;104:441-7.
4. Sousa MM, Saraiva MJ. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog Neurobiol 2003;71:385-400.
5. Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl 1976;590:1-64.
6. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994;235: 479-85.
7. Suhr OB, Svendsen IH, Andersson R, Danielsson A, Holmgren G, Ranlov PJ. Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med 2003;254:225-35.
8. Tashima K, Suhr OB, Ando Y, Holmgren G, Yamashita T, Obayashi K, Terazaki H, et al. Gastrointestinal dysfunction in familial amyloidotic polyneuropathy (ATTR Val30Met)-comparison of Swedish and Japanese patients. Amyloid 1999;6:124-9.
9. Suhr O, Danielsson A, Rydh A, Nyhlin N, Hietala SO, Steen L. Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy. Dig Dis Sci 1996;41:1909-14.
10. Anan I, El-Salhy M, Ando Y, Nyhlin N, Terazaki H, Sakashita N, Suhr O. Colonic endocrine cells in patients with familial amyloidotic polyneuropathy. J Intern Med 1999;245:469-73.
11. el-Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut. 1994;35:1413-8.
12. Nyhlin N, Anan I, el-Salhy M, Ando Y, Suhr OB. Endocrine cells in the upper gastrointestinal tract in relation to gastrointestinal dysfunction in patients with familial amyloidotic polyneuropathy. Amyloid 1999;6:192-8.
13. Yoshimatsu S, Ando Y, Terazaki H, Sakashita N, Tada S, Yamashita T, Suga M, et al. Endoscopic and pathological manifestations of the gastrointestinal tract in familial amyloidotic polyneuropathy type I (Met30). J Intern Med 1998;243:65-72.
14. Ikeda S, Yanagisawa N, Hongo M, Ito N. Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis. J Neurol Sci 1987;79:129-39.
15. Mostafa R-M, Moustafa YM, Hamdy H. Interstitial cells of Cajal, the Maestro in health and disease. World J Gastroenterol 2010;16: 3239-48.
16. Nyhlin N, el-Salhy M, Sandström O, Suhr O. Evaluation of immunohistochemical staining of human duodenal endocrine cells after microwave antigen retrieval. Histochem J 1997;29:177-81.
17. Weibel E, Elias H, eds. Introduction to stereologic principles. In: Quantitative methods in morphology.Berlin: Springer; 1967:89-98.
18. Weibel ER, Stäubli W, Gnägi HR, Hess FA. Correlated morpho-metric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J Cell Biol 1969;42:68-91.
19. el-Salhy M, Sandström O, Näsström E, Mustajbasic M, Zachrisson S. Application of computer image analysis in endocrine cell quantification. Histochem J 1997;29:249-56.
20. Anan I, El-Salhy M, Ando Y, Forsgren S, Nyhlin N, Terazaki H, Sakashita N, et al. Colonic enteric nervous system in patients with familial amyloidotic neuropathy. Acta Neuropathol 1999;98:48-54.
21. Pezzullo JC. JavaStat-retrospective power calculations [Internet]. 2012. Available from: http://statpages.org/postpowr.html [last accessed 2013 Feb 5].
22. Anan I, El-Salhy M, Ando Y, Terazaki H, Suhr OB. Comparison of amyloid deposits and infiltration of enteric nervous system in the upper with those in the lower gastrointestinal tract in patients with familial amyloidotic polyneuropathy. Acta Neuropathol 2001;102: 227-32.
23. Wixner J, Karling P, Rydh A, Hörnsten R, Wiklund U, Anan I, Suhr OB. Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy. Neurogastroenterol Motil 2012; 24:1111-e568.
24. Lang K, Wikström L, Danielsson A, Tashima K, Suhr OB. Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy. Scand J Gastroenterol 2000;35:985-9.
25. Suhr OB, Anan I, Ahlström KR, Rydh A. Gastric emptying before and after liver transplantation for familial amyloidotic polyneurop-athy, Portuguese type (Val30Met). Amyloid 2003;10:121-6.
26. Anan I, El-Salhy M, Nyhlin N, Suhr OB. Liver transplantation restores endocrine cells in patients with familial amyloidotic polyneuropathy. Transplantation 2000;70:794-9.
27. Farrugia G. Interstitial cells of Cajal in health and disease. Neurogastroenterol Motil 2008;20:54-63.
28. Gatopoulou A, Papanas N, Maltezos E. Diabetic gastrointestinal autonomic neuropathy: Current status and new achievements for everyday clinical practice. Eur J Intern Med 2012;23:499-505.
29. Iwasaki H, Kajimura M, Osawa S, Kanaoka S, Furuta T, Ikuma M, Hishida A. A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol 2006;41:1076-87.
30. Nakahara M, Isozaki K, Hirota S, Vanderwinden J-M, Takakura R, Kinoshita K, Miyagawa J-I, et al. Deficiency of KIT-positive cells in the colon of patients with diabetes mellitus. J Gastroenterol Hepatol 2002;17:666-70.
31. Ordög T. Interstitial cells of Cajal in diabetic gastroenteropathy. Neurogastroenterol Motil 2008;20:8-18.
32. Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut 2010;59: 1716-26.
33. Ando Y, Yi S, Nakagawa T, Ikegawa S, Hirota M, Miyazaki A, Araki S. Disturbed metabolism of glucose and related hormones in familial amyloidotic polyneuropathy: hypersensitivities of the autonomic nervous system and therapeutic prevention. J Auton Nerv Syst 1991;35:63-70.
34. Olofsson BO, Grankvist K, Olsson T, Boman K, Forsberg K, Lafvas I, Lithner F. Assessment of hypothalamic-pituitary function in patients with familial amyloidotic polyneuropathy. J Intern Med 1991;229:55-9.
35. Ando Y, Nyhlin N, Suhr O, Holmgren G, Uchida K, El Sahly M, Yamashita T, et al. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem Biophys Res Commun 1997;232: 497-502.
36. Hou X, Aguilar M-I, Small DH. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J 2007;274: 1637-50.
37. Nyhlin N, Anan I, El SM, Ando Y, Suhr OB. Reduction of free radical activity in amyloid deposits following liver transplantation for familial amyloidotic polyneuropathy. J Intern Med 2002;251: 136-41.
38. Choi KM, Kashyap PC, Dutta N, Stoltz GJ, Ordog T, Shea Donohue T, Bauer AJ, et al. CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology 2010;138:2399-2409.
39. Bharucha AE, Kulkarni A, Choi KM, Camilleri M, Lempke M, Brunn GJ, Gibbons SJ, et al. First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Clin Pharmacol Ther 2010;87:187-90.
40. Kashyap PC, Choi KM, Dutta N, Linden DR, Szurszewski JH, Gibbons SJ, Farrugia G. Carbon monoxide reverses diabetic gastroparesis in NOD mice. Am J Physiol Gastrointest Liver Physiol 2010;298:G1013-19.
41. Suhr OB, Lang K, Wikström L, Anan I, Ando Y, El-Salhy M, Holmgren G, et al. Scavenger treatment of free radical injury in familial amyloidotic polyneuropathy: a study on Swedish transplanted and non-transplanted patients. Scand J Clin Lab Invest 2001;61:11-8.
42. Gomez-Pinilla PJ, Gibbons SJ, Sarr MG, Kendrick ML, Robert Shen K, Cima RR, Dozois EJ, et al. Changes in interstitial cells of cajal with age in the human stomach and colon. Neurogastroenterol Motil 2011;23:36-44.
43. Donthireddy KR, Ailawadhi S, Nasser E, Schiff MD, Nwogu CE, Nava HR, Javle MM. Malignant gastroparesis: pathogenesis and management of an underrecognized disorder. J Support Oncol 2007;5:355-63.